Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Dorota, Dajnowiec"'
Autor:
Bernie D. Sattin, Yanli Wang, Dorota Dajnowiec, Kinda Karra, Cynthia H. Seow, Long-long Gao, Brian Bressler, Waqqas Afif, Reena Khanna, Martin Williamson
Publikováno v:
Digestive Diseases and Sciences. 67:3148-3157
The value of ustekinumab (UST) therapeutic drug monitoring (TDM) in clinical practice remains unclear. This study examined the impact of UST TDM on clinical decision making in patients with Crohn’s disease (CD). A total of 110 consecutive UST-treat
Autor:
Martin Williamson, Tracy S. H. In, Maureen Hazel, Michael J. Stewart, Kinda Karra, Bernie D. Sattin, Dorota Dajnowiec, Talat Bessissow, James C. Gregor
Publikováno v:
Advances in Therapy. 38:4115-4129
Adalimumab and golimumab are subcutaneously administered anti-tumor necrosis factor α (TNFα) biologics used in the treatment of ulcerative colitis (UC). To date, no studies have directly compared treatment patterns and healthcare resource utilizati
Autor:
Michael J, Stewart, Talat, Bessissow, James, Gregor, Maureen, Hazel, Tracy S H, In, Kinda, Karra, Dorota, Dajnowiec, Martin, Williamson, Bernie, Sattin
Publikováno v:
Advances in therapy. 38(7)
Adalimumab and golimumab are subcutaneously administered anti-tumor necrosis factor α (TNFα) biologics used in the treatment of ulcerative colitis (UC). To date, no studies have directly compared treatment patterns and healthcare resource utilizati
Autor:
Martin Williamson, Waqqas Afif, Bernie D. Sattin, Reena Khanna, Cynthia H. Seow, Dorota Dajnowiec, Long-Long Gao, K Karra, mUST-Decide, Brian Bressler
Publikováno v:
Journal of Crohn's and Colitis. 14:S443-S444
Background Therapeutic drug monitoring is an important adjunct in optimising IBD management in patients treated with anti-TNF therapies. However, it remains unclear whether these principles apply to non-anti-TNF biologic therapies, such as the anti-I
Autor:
Long-Long Gao, Dorota Dajnowiec, Martin Williamson, Cynthia H. Seow, Reena Khanna, Brian Bressler, Kinda Karra, Bernie D. Sattin, Waqqas Afif
Publikováno v:
Gastroenterology. 158:S-464
Autor:
Bernie D. Sattin, Dorota Dajnowiec, Martin Williamson, Erik Sabot, Baljinder Salh, James C. Gregor
Publikováno v:
Patient preference and adherence
James C Gregor,1 Martin Williamson,2 Dorota Dajnowiec,2 Bernie Sattin,2 Erik Sabot,3 Baljinder Salh4 1Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada; 2Janssen Inc., Toronto, ON, Canada; 3OptumInsight, Bos
Autor:
K Karra, Martin Williamson, Brian Bressler, Bernie D. Sattin, Dorota Dajnowiec, Waqqas Afif, G Long-Long
Publikováno v:
Journal of Crohn's and Colitis. 13:S394-S395
Autor:
Jennifer, Jones, Mark, Borgaonkar, Jesse, Siffledeen, Ryan, O'Reilly, Dana, Anger, Dorota, Dajnowiec, Martin, Williamson, Peter, Dyrda
Publikováno v:
Managed care (Langhorne, Pa.). 26(2)
To understand the perception of intravenous infusions in patients receiving infliximab (Remicade) within the BioAdvance patient support program (PSP).Intravenous infusion of infliximab occurs at approximately 200 clinics across Canada and is managed
Autor:
Martin Williamson, Dorota Dajnowiec, Talat Bessissow, Maureen Hazel, Michael J. Stewart, James C. Gregor, Kinda Karra, Bernie D. Sattin
Publikováno v:
Gastroenterology. 156:S-645
Autor:
Bernie D. Sattin, Waqqas Afif, Long-Long Gao, Dorota Dajnowiec, Kinda Karra, Brian Bressler, Martin Williamson
Publikováno v:
Gastroenterology. 156:S-1144